Home Novo Nordisk to end German sales of new insulin drug after price row
 

Keywords :   


Novo Nordisk to end German sales of new insulin drug after price row

2015-07-01 20:23:39| Biotech - Topix.net

COPENHAGEN: Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy about the high cost of modern medicines.

Tags: price end sales german

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11AKB48 1st
14.11kindle 10
14.11
14.11YAMAHA PORTATONE PSR-340
14.112003 112
14.11 14533.5
14.11caligari 17
14.11 amnjx 27circus
More »